An interventional study of Early mobilisation in Cardiac Disease, sponsored by Ahi Evran University Education and Research Hospital. Enrolling by invitation at 1 site in Turkey. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2024-04-11.
Sponsored by Ahi Evran University Education and Research Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 34 studies in Heart Diseases with a site in Turkey — 6 open to participants now, 8 under way, 2 of them phase 3. Heart Diseases · Turkey.
Among the 34 studies in Heart Diseases with a site in Turkey, this one is the 11th largest by planned enrollment of the 23 interventional ones that give a count, is one of 4 that started in 2023, is one of 15 with no phase, and was the 25th registered.
2,135 studies on the registry are indexed under Heart Diseases; 250 are open to participants now.
Browse Heart Diseases studies →6 of the 34 studies in Heart Diseases with a site in Turkey are open now. Recruiting first, the newest first:
Eli Lilly and Company · Sites in Turkey, Argentina, Australia and 35 more countries
Ages 50+
Istanbul University - Cerrahpasa · Sites in Turkey
Ages 18+
P+F Products + Features GmbH · Sites in Turkey, Argentina, Brazil and 5 more countries
Ages 65+
Occlutech International AB · Sites in Turkey, Germany
Taewoong Medical Co., Ltd. · Sites in Turkey, Germany, Italy and 3 more countries
Ages 10+
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 182 Heart Diseases studies recruiting now, 128 (70%) set no upper age limit and 22 (12%) stop at 75 or younger; 33 take children under 18; 41 take healthy volunteers.
This study: 65 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
34 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 4 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 100 is below the median of 129 across 931 interventional studies indexed under Heart Diseases.
Median enrollment 70 across the 23 interventional studies, 239 across the 11 observational. Of the 22 that completed or were terminated, 6 (27%) have results posted.
This tab as a report to print or save as PDF → With an account.
12 of 34 have an industry lead sponsor. The 10 most frequent:
Ahi Evran University Education and Research Hospital is the lead sponsor of 39 studies on the registry; 4 are open to participants now.
Ahi Evran University Education and Research Hospital has 1 study filed under Heart Diseases — fewer than ten, so there is no comparison to draw.
1 of the studies in Heart Diseases with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05174442Occlutech International ABACCESS Registry: A Post Market Follow-up Study to Monitor the Safety, Performance and Usability of Occlutech Accessory Medical Devices | 2027-01-01 |
Add it to your calendar (.ics) → With an account.
Among the 34 studies in Heart Diseases with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Heart and blood vessel problems together referred to as cardiovascular diseases (CVD) include congenital heart disease, cerebrovascular illness, and coronary heart disease.
Following heart surgery, patients who are active in the postoperative phase stay in the hospital for shorter periods of time and experience fewer complications.
After cardiac surgery, older adults who exercise during the recovery period experience fewer difficulties and hospitalizations.
A total of 100 elderly patients-69 men and 31 women-who had undergone cardiac surgery and were up to 65 years old-voluntarily took part in the study. There were fifty patients in each of the two groups that the participants were divided into: the early mobilization group (Group A) and the control group (Group B).
Older patients undergoing cardiac surgery also experienced improved balance as a result of early mobilization and functional exercises.
A total of 100 geriatric patients-69 men and 31 women-who had undergone heart surgery and were up to 65 years old-voluntarily took part in the study. There were fifty patients in each of the two groups that the participants were divided into: the early mobilization group (Group A) and the control group (Group B). The patients in early mobilization group underwent early mobilization and functional exercises program, while the patients served as the control group did not receive the therapy protocol applied in the early mobilization group
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Individuals who had previously had valve replacement procedures or coronary artery bypass grafting (CABG) and if all of these procedures were done by sternotomy were included in the study. The study's patients were all classified as geriatric, with ages ranging from 65 to 75. There were people of both genders in the sample. Throughout their recovery, patients who were awake, conscious, and able to communicate vocally as well as those who were able to understand and complete scales and questionnaires. Patients who signed consent forms voluntarily agreed to participate, as well as those who successfully passed the two-minute walk test (2MWT), which assesses how long it takes to walk for two minutes.
Exclusion Criteria:
The patients in early mobilization group underwent early mobilization and functional exercises program, while the patients served as the control group did not receive the therapy protocol applied in the early mobilization group
Other: Early mobilisation
The patients in early mobilization group underwent early mobilization and functional exercises program, while the patients served as the control group did not receive the therapy protocol applied in the early mobilization group
Other: Early mobilisation
Breathing exercises, inspiratory muscle strength, postural drainage, functional exercise (stand up and sitting down on the chair, walking inward, back-ward ,and sideways), weight shifts from left to right, step up inside the patch , one leg stand, squatting leaning against wall) for three times per the day and repetition fifteen times (3 times per day for 15 repetition) and supervised walking with increments of 2 minutes, as tolerated up to 6 minutes or more at the morning, afternoon, evening and at night.
International Physical Activity Questionnaire
The Short Form of the International Physical Activity Questionnaire (SF-IPAQ) was used to measure physical activity (PA). Participants were asked to describe how many days they had spent performing vigorous, moderate, and walking activities over the course of the previous week, as well as the duration of those activities
Time frame: 0-7 days
Two Minute Walking Test
The 2MWT was performed over a 50-ft (15.2-m) out-and-back course. Participants were instructed to walk as fast as they could until asked to stop. They were also told not to worry if they had to slow down or rest, but that if they stopped they should start walking again as soon as they felt ready to do so. When 1 minute had elapsed, they were told "You are doing well; you have 1 minute left." Participants stopped walking at 2 minutes, and the distance covered was documented
Time frame: 0-7 days
Plan to share: No
Ran from Apr 2023 to primary completion in Jun 2023, 2 months.
Of 264 non-industry interventional studies with no phase under Heart Diseases, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 51. This study's 2 months is below that.
Counting every sponsor, half of 337 studies reached it within 25 months; a quarter within 11 and three quarters within 52.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ahi Evran University Education and Research Hospital